Next Article in Journal
Friction-Induced Mitochondrial Dysregulation Contributes to Joint Deterioration in Prg4 Knockout Mice
Next Article in Special Issue
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure
Previous Article in Journal
Transcriptional Responses in the Murine Spleen after Toxoplasma gondii Infection: Inflammasome and Mucus-Associated Genes
Previous Article in Special Issue
Cholesterol Crystal Embolism and Chronic Kidney Disease
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(6), 1248; doi:10.3390/ijms18061248

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases

1
Department of Nephrology, Hypertension and Family Medicine, WAM Teaching Hospital, Lodz 90-549, Poland
2
Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Lodz 90-549, Poland
3
Department of Ultrasound, Institute of Fundamental Technological Research, Polish Academy of Sciences (IPPT PAN), Warsaw 02-106, Poland
4
Department of Hypertension, Medical University of Lodz, Lodz 90-549, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: Alan Parrish
Received: 3 April 2017 / Revised: 19 May 2017 / Accepted: 27 May 2017 / Published: 10 June 2017
(This article belongs to the Special Issue Advances in Chronic Kidney Disease 2017)
View Full-Text   |   Download PDF [897 KB, uploaded 10 June 2017]   |  

Abstract

The prevalence of renal diseases is rising and reaching 5–15% of the adult population. Renal damage is associated with disturbances of body homeostasis and the loss of equilibrium between exogenous and endogenous elements including drugs and metabolites. Studies indicate that renal diseases are influenced not only by environmental but also by genetic factors. In some cases the disease is caused by mutation in a single gene and at that time severity depends on the presence of one or two mutated alleles. In other cases, renal disease is associated with the presence of alteration within a gene or genes, but environmental factors are also necessary for the development of disease. Therefore, it seems that the analysis of genetic aspects should be a natural component of clinical and experimental studies. The goal of personalized medicine is to determine the right drug, for the right patient, at the right time. Whole-genome examinations may help to change the approach to the disease and the patient resulting in the creation of “personalized medicine” with new diagnostic and treatment strategies designed on the basis of genetic background of each individual. The identification of high-risk patients in pharmacogenomics analyses will help to avoid many unwarranted side effects while optimizing treatment efficacy for individual patients. Personalized therapies for kidney diseases are still at the preliminary stage mainly due to high costs of such analyses and the complex nature of human genome. This review will focus on several areas of interest: renal disease pathogenesis, diagnosis, treatment, rate of progression and the prediction of prognosis. View Full-Text
Keywords: renal diseases; personalized medicine; treatment; diagnosis; biomarkers renal diseases; personalized medicine; treatment; diagnosis; biomarkers
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Gluba-Brzózka, A.; Franczyk, B.; Olszewski, R.; Banach, M.; Rysz, J. Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases. Int. J. Mol. Sci. 2017, 18, 1248.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top